Exiqon A/S (NASDAQ OMX: EXQ.CO), a leading supplier of high-value gene
expression analysis products, and AROS Applied Biotechnology A/S, a leading
supplier of total genomic solutions services, today announced that they have
signed a Center of Excellence agreement allowing AROS to provide real-time PCR
services based on Exiqon's miRCURY LNA™ Universal RT microRNA PCR product line.
The agreement is part of Exiqon's certified service provider program.

LNA™-based microRNA profiling holds great promise as a non-invasive way to
discover important new biomarkers for a wide range of diseases and biological
processes. The extreme sensitivity obtained by inclusion of LNA™ in the PCR
primers allows for the profiling of non-invasive samples like serum and plasma
where the quantity of RNA is extremely low.

“We see an increased demand for high quality miRNA analysis from both
pharmaceutical companies and research institution. AROS has had a very positive
collaboration with Exiqon for a number of years. We are convinced that Exiqon's
miRCURY LNA™ Universal RT microRNA PCR product line is a strong addition to our
offering”, said Brian Sørensen, CEO at AROS.

“We are excited to include AROS in our Center of Excellence program”, said
Henrik M Pfundheller, Ph.D., SVP Sales & Marketing and added: “AROS is a
well-reputed company with strong experience working with i.e. blood samples
from clinical studies. We see an increasing demand for microRNA profiling from
body fluids such as serum/plasma and urine, and we are confident that we have a
strong partner in AROS”.

Additional information:

Lars Kongsbak, President and CEO, Exiqon A/S, tel. +45 4566 0888 (cell: +45
4090 2101)

Henrik M. Pfundheller, Senior Vice President Sales & Marketing, Exiqon A/S,
tel. +45 4565 0420 (cell: +45 4090 2106)

Brian Sørensen, CEO, AROS Applied Biotechnology A/S (cell: + 45 28 19 25 80)

Mogens Kruhøffer, CSO, AROS Applied Biotechnology A/S (cell: + 45 28 19 26 82)


See the full press release in the attached PDF or at
www.exiqon.com/investor/portal

PressRelease_September2011_CoE_Aros.pdf